The Discounted Cash Flow (DCF) valuation of Codiak BioSciences, Inc. (CDAK) is (9.05) USD. With the latest stock price at 0.06 USD, the upside of Codiak BioSciences, Inc. based on DCF is -15980.7%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.3% - 10.1% | 8.2% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (27.15) - (5.61) | (9.05) |
| Upside | -47724.9% - -9945.9% | -15980.7% |